Effects of combined THC and heroin vapor inhalation in rats

[1]  A. Gutierrez,et al.  A vapor exposure method for delivering heroin alters nociception, body temperature and spontaneous activity in female and male rats , 2020, Journal of Neuroscience Methods.

[2]  E. Weerts,et al.  Translational models of cannabinoid vapor exposure in laboratory animals , 2020, Behavioural pharmacology.

[3]  E. Weerts,et al.  Antinociceptive, hypothermic, and appetitive effects of vaped and injected Δ9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex , 2020 .

[4]  M. Olfson,et al.  Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis. , 2020, Addiction.

[5]  S. Montgomery,et al.  Marijuana users are likely to report opioid misuse among adults over 50 years in representative sample of the United States (2002–2014) , 2020, Journal of addictive diseases.

[6]  Brandon J. Henderson,et al.  Flavors enhance nicotine vapor self-administration in male mice. , 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[7]  Jude A Frie,et al.  OpenVape: An Open-Source E-Cigarette Vapor Exposure Device for Rodents , 2020, eNeuro.

[8]  Jordan P. Davis,et al.  Developmental Trajectories of Tobacco/Nicotine and Cannabis Use and Patterns of Product Co-use in Young Adulthood , 2020, Tobacco use insights.

[9]  G. Koob,et al.  Fentanyl vapor self-administration model in mice to study opioid addiction , 2020, Science Advances.

[10]  Jennifer D. Thomas,et al.  Combined Vapor Exposure to THC and Alcohol in Pregnant Rats: Maternal Outcomes and Pharmacokinetic Effects , 2020, bioRxiv.

[11]  B. Reboussin,et al.  Trajectories of cannabis use and risk for opioid misuse in a young adult urban cohort. , 2020, Drug and alcohol dependence.

[12]  B. Reboussin,et al.  Adolescent cannabis and tobacco use are associated with opioid use in young adulthood-12-year longitudinal study in an urban cohort. , 2020, Addiction.

[13]  S. Ferguson,et al.  One Is Not Enough: Understanding and Modeling Polysubstance Use , 2020, Frontiers in Neuroscience.

[14]  M. Sylvestre,et al.  Type of e-liquid vaped, poly-nicotine use and nicotine dependence symptoms in young adult e-cigarette users: a descriptive study , 2020, BMC Public Health.

[15]  T. Kerr,et al.  Explication of CB1 receptor contributions to the hypothermic effects of Δ9-tetrahydrocannabinol (THC) when delivered by vapor inhalation or parenteral injection in rats , 2020, bioRxiv.

[16]  M. Cole,et al.  Effects of Δ⁹-tetrahydrocannabinol (THC) vapor inhalation in Sprague-Dawley and Wistar rats. , 2020, Experimental and clinical psychopharmacology.

[17]  A. Gutierrez,et al.  Female rats self-administer heroin by vapor inhalation , 2020, Pharmacology Biochemistry and Behavior.

[18]  Jennifer L. Pearson,et al.  It's past time to consider cannabis in vaping research. , 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[19]  Matthew W Buczynski,et al.  Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems , 2020, Journal of Neuroscience Methods.

[20]  R. McLaughlin,et al.  Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats , 2019, The Journal of Neuroscience.

[21]  N. Nicksic,et al.  Cannabis legalization, tobacco prevention policies, and Cannabis use in E-cigarettes among youth. , 2019, Drug and alcohol dependence.

[22]  C. Montanari,et al.  Nicotine e-cigarette vapor inhalation effects on nicotine & cotinine plasma levels and somatic withdrawal signs in adult male Wistar rats , 2019, Psychopharmacology.

[23]  C. France,et al.  Effects of the synthetic cannabinoid receptor agonist JWH-018 on abuse-related effects of opioids in rhesus monkeys. , 2019, Drug and alcohol dependence.

[24]  Jon-Patrick Allem,et al.  E-liquid-related posts to Twitter in 2018: Thematic analysis , 2019, Addictive behaviors reports.

[25]  M. Javadi-Paydar,et al.  Vapor inhalation of cannabidiol (CBD) in rats , 2019, Pharmacology Biochemistry and Behavior.

[26]  G. Zarkin,et al.  Vaping cannabis among adolescents: prevalence and associations with tobacco use from a cross-sectional study in the USA , 2019, BMJ Open.

[27]  K. Janda,et al.  Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions , 2017, Neuropharmacology.

[28]  M. Cole,et al.  Effects of Nicotine and THC Vapor Inhalation Administered by An Electronic Nicotine Delivery System (ENDS) in Male Rats , 2018, bioRxiv.

[29]  K. Janda,et al.  Prophylactic vaccination protects against the development of oxycodone self-administration , 2018, Neuropharmacology.

[30]  C. France,et al.  Reinforcing effects of opioid/cannabinoid mixtures in rhesus monkeys responding under a food/drug choice procedure , 2018, Psychopharmacology.

[31]  M. Cole,et al.  Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats , 2018, Pharmacology Biochemistry and Behavior.

[32]  Stephanie A. Carmack,et al.  Compulsive-Like Sufentanil Vapor Self-Administration in Rats , 2018, Neuropsychopharmacology.

[33]  P. T. Bremer,et al.  Effective active vaccination against methamphetamine in female rats. , 2017, Drug and alcohol dependence.

[34]  M. Cole,et al.  Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats , 2017, bioRxiv.

[35]  L. Parsons,et al.  Inhaled delivery of Δ9-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology , 2016, Neuropharmacology.

[36]  M. Cole,et al.  Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology , 2016, Neuropsychopharmacology.

[37]  M. Zoli,et al.  Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice , 2015, European Neuropsychopharmacology.

[38]  L. Parsons,et al.  Endocannabinoid signalling in reward and addiction , 2015, Nature Reviews Neuroscience.

[39]  M. Taffe,et al.  Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9‐tetrahydrocannabinol in Sprague‐Dawley rats , 2015, British journal of pharmacology.

[40]  Nicole M. Lauzon,et al.  Cannabinoid Transmission in the Prelimbic Cortex Bidirectionally Controls Opiate Reward and Aversion Signaling through Dissociable Kappa Versus μ-Opiate Receptor Dependent Mechanisms , 2013, The Journal of Neuroscience.

[41]  T. Dickerson,et al.  The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in rats , 2013, Neuropharmacology.

[42]  C. France,et al.  Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[43]  S. Barrett,et al.  Substance use initiation: the role of simultaneous polysubstance use. , 2013, Drug and alcohol review.

[44]  K. Houseknecht,et al.  Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone). , 2013, Drug and alcohol dependence.

[45]  L. Parsons,et al.  Effect of Ambient Temperature on the Thermoregulatory and Locomotor Stimulant Effects of 4-Methylmethcathinone in Wistar and Sprague-Dawley Rats , 2012, PloS one.

[46]  R. Craft,et al.  THC−methadone and THC−naltrexone interactions on discrimination, antinociception, and locomotion in rats , 2011, Behavioural pharmacology.

[47]  L. Panlilio,et al.  Animal models of cannabinoid reward , 2010, British journal of pharmacology.

[48]  D. Lichtermann,et al.  Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs , 2010, International Journal of Legal Medicine.

[49]  C. France,et al.  Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception , 2008, Psychopharmacology.

[50]  J. Traynor,et al.  Comparison of the Antinociceptive Response to Morphine and Morphine-Like Compounds in Male and Female Sprague-Dawley Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.

[51]  Z. Justinova,et al.  Self-administration of Delta(9)-tetrahydrocannabinol (THC) bydrug naive squirrel monkeys , 2004 .

[52]  S. Goldberg,et al.  Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys , 2003, Psychopharmacology.

[53]  D. Amaral,et al.  Reduction in Opioid- and Cannabinoid-Induced Antinociception in Rhesus Monkeys after Bilateral Lesions of the Amygdaloid Complex , 2001, The Journal of Neuroscience.

[54]  B. Wainer,et al.  Effects of passive immunization against morphine on heroin self-administration , 1978, Pharmacology Biochemistry and Behavior.

[55]  B. Blakesley,et al.  Intravenous self-administration of heroin in the rat: experimental technique and computer analysis. , 1972, British Journal of Pharmacology.